Evidence map›Paper›PMID 37225889›Full record

ReviewBriefings in functional genomics2024

Quantifying transcriptome diversity: a review.

Emma F Jones, Anisha Haldar, Vishal H Oza, Brittany N Lasseigne

Abstract readReview
In one paragraph

Review in Briefings in functional genomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Perplexity as a Metric for Isoform Diversity in the Human Transcriptome.bioRxiv : the preprint server for biology · 2025
    Article
  13. Article
  14. Integrative transcriptomic analysis reveals alternative splicing complexity and transcriptomic diversity in porcine placentas across altitudes.DNA research : an international journal for rapid publication of reports on genes and genomes · 2025
    Article
  15. Article
  16. Article
  17. Two detoxification enzyme genes,Frontiers in physiology · 2024
    Article
  18. Human transcriptional signature of protection afterHuman vaccines & immunotherapeutics · 2023
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Emma F JonesThe Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0003-4244-1456
Anisha HaldarThe Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-1395-9793
Vishal H OzaThe Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0001-6990-0267
Brittany N LasseigneThe Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-1642-8904

Funding

Integrating multidimensional genomic data to discover clinically-relevant predictive models-Alzheimer's SupplementR00HG009678 · NHGRI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LASSEIGNE, BRITTANY NICOLE · 2019 to 2021
$961k
NHGRI NIH HHS R00 HG009678
6 · The paper itself

Abstract

Following the central dogma of molecular biology, gene expression heterogeneity can aid in predicting and explaining the wide variety of protein products, functions and, ultimately, heterogeneity in phenotypes. There is currently overlapping terminology used to describe the types of diversity in gene expression profiles, and overlooking these nuances can misrepresent important biological information. Here, we describe transcriptome diversity as a measure of the heterogeneity in (1) the expression of all genes within a sample or a single gene across samples in a population (gene-level diversity) or (2) the isoform-specific expression of a given gene (isoform-level diversity). We first overview modulators and quantification of transcriptome diversity at the gene level. Then, we discuss the role alternative splicing plays in driving transcript isoform-level diversity and how it can be quantified. Additionally, we overview computational resources for calculating gene-level and isoform-level diversity for high-throughput sequencing data. Finally, we discuss future applications of transcriptome diversity. This review provides a comprehensive overview of how gene expression diversity arises, and how measuring it determines a more complete picture of heterogeneity across proteins, cells, tissues, organisms and species.

Indexed as

Gene Expression ProfilingTranscriptomeAlternative SplicingHigh-Throughput Nucleotide SequencingProtein IsoformsSequence Analysis, RNAProtein Isoformsgene expressiongene-level diversityisoform-level diversitytranscript diversitytranscriptional variationtranscriptome diversity

Identifiers

PMID37225889
PMCPMC11484519

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.